Nimotuzumab as Additional Therapy for GLIOMA in Pediatric and Adolescent: A Systematic Review

• Main Authors: Muhammad Arifin Parenrengi, Wihasto Suryaningtyas, Asra Al Fauzi, Abdul Hafid Bajamal, Kurnia Kusumastuti, Budi Utomo, Ahmad Muslim Hidayat Thamrin, Bagus Sulistiono
• Format: Article PeerReviewed
• Language: English; Indonesian; English; English
• Published: sage 2022
• Subjects: R5-920 Medicine (General)
• Online Access: https://repository.unair.ac.id/124342/1/11%2C%20Jurnal%20Nimotuzumab.pdf; https://repository.unair.ac.id/124342/2/11%2C%20Karil%20Bidang%20Ilmu%20%28Nimotizumab%29.pdf; https://repository.unair.ac.id/124342/3/11.%20Nimotuzumab.pdf; https://repository.unair.ac.id/124342/6/11.%20Korespondensi%20NItozumab....pdf; https://repository.unair.ac.id/124342/
• Institution: Universitas Airlangga

Abstract Introduction: Pediatric gliomas represent the most common brain tumor in children and its higher grades are associated with higher recurrence and low survival rate. All therapeutic modalities are reported to be insufficient to achieve satisfactory result, with follow-up treatment such as a...